Patterson Companies (PDCO)
(Delayed Data from NSDQ)
$20.27 USD
-0.01 (-0.05%)
Updated Oct 8, 2024 03:59 PM ET
After-Market: $20.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.27 USD
-0.01 (-0.05%)
Updated Oct 8, 2024 03:59 PM ET
After-Market: $20.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Zacks News
Patterson Cos. (PDCO) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Patterson Companies (PDCO) Misses on Q3 Earnings, Lowers EPS View
by Zacks Equity Research
Patterson Companies' (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.
Patterson Cos. (PDCO) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -1.67% and 1.02%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Patterson Companies (PDCO) in Q3 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.
Patterson Cos. (PDCO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of Patterson Cos. (PDCO) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Patterson Cos. (PDCO) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Patterson Cos. (PDCO) closed at $28.40 in the latest trading session, marking a +0.18% move from the prior day.
Patterson Cos. (PDCO) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Patterson Cos. (PDCO) closed the most recent trading day at $29.09, moving +1.43% from the previous trading session.
Patterson Cos. (PDCO) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Patterson Cos. (PDCO) closed the most recent trading day at $28.97, moving -0.52% from the previous trading session.
Patterson Cos. (PDCO) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
The latest trading day saw Patterson Cos. (PDCO) settling at $30.05, representing a +0.07% change from its previous close.
Patterson Cos. (PDCO) Laps the Stock Market: Here's Why
by Zacks Equity Research
Patterson Cos. (PDCO) concluded the recent trading session at $30.34, signifying a +1.71% move from its prior day's close.
Patterson Cos. (PDCO) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the most recent trading session, Patterson Cos. (PDCO) closed at $30.16, indicating a -0.56% shift from the previous trading day.
Patterson Cos. (PDCO) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Patterson Cos. (PDCO) stood at $29.63, denoting a +0.73% change from the preceding trading day.
Why Is Patterson Cos. (PDCO) Up 12.1% Since Last Earnings Report?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Companies (PDCO) Q2 Earnings Miss, EPS View Lowered
by Zacks Equity Research
Patterson Companies' (PDCO) second-quarter fiscal 2024 results reflect improvement in Dental Consumable sales, which were offset by lower Dental Equipment sales. Animal health sales improve.
Compared to Estimates, Patterson Cos. (PDCO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended October 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
What's in Store for Patterson Companies (PDCO) in Q2 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.
Exploring Analyst Estimates for Patterson Cos. (PDCO) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Patterson Cos. (PDCO) for the quarter ended October 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Patterson Cos. (PDCO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Patterson Cos. (PDCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Patterson Companies (PDCO) Partners With Pearl for AI Services
by Zacks Equity Research
Patterson Companies (PDCO) collaborates with dental AI solution provider, Pearl, to integrate the latter's Second Opinion software solution within its Eaglesoft software to deliver advanced solutions.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Patterson Cos. (PDCO) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Patterson Cos. (PDCO) closed at $32.03 in the latest trading session, marking a +0.03% move from the prior day.
Are Investors Undervaluing Patterson Companies (PDCO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now
by Zacks Equity Research
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
PDCO or MMSI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Here's Why You Should Retain CONMED (CNMD) Stock for Now
by Zacks Equity Research
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.